2024-510644-31-00CompletedPhase 1
To Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination with Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Apr 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 6 Mar 2024
- Start date
- 10 Jun 2022
- Lead sponsor
- Genentech Inc.
- Diseases
- Multiple myeloma
- EU CT number
- 2024-510644-31-00
- EudraCT number
- 2021-003295-13
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 50
- 14 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (14)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Odense University Hospital | Odense C | Denmark | Completed |
| Lillebaelt Hospital | Vejle | Denmark | Completed |
| Hospital Germans Trias i Pujol | Badalona | Spain | Completed |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | Completed |
| Hospital Clinic de Barcelona | Barcelona | Spain | Completed |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Institut Català d'Oncologia | Girona | Spain | Completed |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat | Spain | Completed |
| Hospital Universitario de la Princesa | Madrid | Spain | Completed |
| Hospital Universitario Quironsalud Madrid | Pozuelo de Alarcón | Spain | Completed |
| Hospital Universitario De Salamanca | Salamanca | Spain | Completed |
| University Hospital Virgen Del Rocio S.L. | Sevilla | Spain | Completed |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Completed |
| Oslo University Hospital HF | Oslo | Norway | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.